Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

FebriDx® Pediatric Validation Study

NCT: NCT07211997 · RECRUITING

NCT IDNCT07211997
StatusRECRUITING
Start Date2025-10-09
Completion2027-05-30
SponsorLumos Diagnostics (INDUSTRY)
First posted
Last updated

Brief Summary

The primary objective of this study is to determine performance characteristics of the FebriDx® test in differentiating bacterial from non-bacterial etiology among febrile pediatric patients (2-11 years) presenting to the emergency department, urgent care center or primary care office with a suspected acute respiratory tract infection.

Frequently Asked Questions

What is FebriDx® Pediatric Validation Study?

FebriDx® Pediatric Validation Study is a clinical trial registered under NCT07211997. Current status: RECRUITING.

What is the status of NCT07211997?

The current status of NCT07211997 (FebriDx® Pediatric Validation Study) is: RECRUITING.

When did FebriDx® Pediatric Validation Study start?

FebriDx® Pediatric Validation Study started on 2025-10-09.

Related Devices

K230917FebriDx Bacterial / Non-bacterial Point of Care AssayLumos Diagnostics, Inc. K260787FebriDx Bacterial/Non-bacterial AssayLumos Diagnostics, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑